Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies
Abstract Introduction The aim of our analysis was to compare the effectiveness of the XEN45 gel stent implantation in patients without and with prior glaucoma intervention. Methods Retrospective analysis including 148 medical records of consecutive glaucoma eyes without prior glaucoma intervention (...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2019-06-01
|
| Series: | Ophthalmology and Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1007/s40123-019-0193-7 |
| _version_ | 1811294157894844416 |
|---|---|
| author | Fritz H. Hengerer Gerd Auffarth Ina Conrad-Hengerer |
| author_facet | Fritz H. Hengerer Gerd Auffarth Ina Conrad-Hengerer |
| author_sort | Fritz H. Hengerer |
| collection | DOAJ |
| description | Abstract Introduction The aim of our analysis was to compare the effectiveness of the XEN45 gel stent implantation in patients without and with prior glaucoma intervention. Methods Retrospective analysis including 148 medical records of consecutive glaucoma eyes without prior glaucoma intervention (group A, n = 45) or with prior glaucoma intervention (group B, n = 103). Follow-up data up to 12 months after XEN45 gel implantation were available for all eyes. Results At 12 months, qualified success (IOP reduction of ≥ 20% and IOP < 18 mmHg without and with medication) was achieved in 76% of eyes in group A and in 72% of eyes in group B; corresponding values for complete success (IOP reduction of ≥ 20% and IOP < 18 mmHg without medication) were 56% and 55%. Mean IOP was significantly reduced by 58% from 36.0 ± 10.7 mmHg preoperatively to 14.2 ± 3.4 mmHg at 12 months in group A (p = 0.000) and by 53% from 31.6 ± 8.9 mmHg to 14.3 ± 4.2 mmHg and in group B (p = 0.000). The mean number of hypotensive medications had significantly decreased from 3.6 ± 0.8 at baseline to 0.3 ± 0.7 medications in group A (p = 0.000) and from 3.0 ± 1.0 to 0.3 ± 0.7 medications in group B (p = 0.000). Needling was required in 29% of eyes in group A and in 35% of group B within 12 months. No statistically significant differences were observed between eyes without and with prior glaucoma intervention. Conclusion The 1-year results of our retrospective analysis indicate that patients without and with previous glaucoma intervention can benefit from XEN45 gel stent implantation. Both groups achieved significant and similar reductions in IOP and hypotensive medication, with a slight trend towards greater reductions in eyes without prior glaucoma intervention. Further controlled prospective studies with longer follow-ups are required. Funding Editorial support and article processing charges were funded by Allergan. |
| first_indexed | 2024-04-13T05:13:18Z |
| format | Article |
| id | doaj.art-d32d41bb074a44b6abd6c2a5d8aaadb0 |
| institution | Directory Open Access Journal |
| issn | 2193-8245 2193-6528 |
| language | English |
| last_indexed | 2024-04-13T05:13:18Z |
| publishDate | 2019-06-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Ophthalmology and Therapy |
| spelling | doaj.art-d32d41bb074a44b6abd6c2a5d8aaadb02022-12-22T03:00:59ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282019-06-018344745910.1007/s40123-019-0193-7Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional TherapiesFritz H. Hengerer0Gerd Auffarth1Ina Conrad-Hengerer2Department of Ophthalmology, Bürgerhospital und Clementine Kinderhospital gemeinnützige GmbHInternational Vision Correction Research Center (IVCRC), University of HeidelbergInternational Vision Correction Research Center (IVCRC), University of HeidelbergAbstract Introduction The aim of our analysis was to compare the effectiveness of the XEN45 gel stent implantation in patients without and with prior glaucoma intervention. Methods Retrospective analysis including 148 medical records of consecutive glaucoma eyes without prior glaucoma intervention (group A, n = 45) or with prior glaucoma intervention (group B, n = 103). Follow-up data up to 12 months after XEN45 gel implantation were available for all eyes. Results At 12 months, qualified success (IOP reduction of ≥ 20% and IOP < 18 mmHg without and with medication) was achieved in 76% of eyes in group A and in 72% of eyes in group B; corresponding values for complete success (IOP reduction of ≥ 20% and IOP < 18 mmHg without medication) were 56% and 55%. Mean IOP was significantly reduced by 58% from 36.0 ± 10.7 mmHg preoperatively to 14.2 ± 3.4 mmHg at 12 months in group A (p = 0.000) and by 53% from 31.6 ± 8.9 mmHg to 14.3 ± 4.2 mmHg and in group B (p = 0.000). The mean number of hypotensive medications had significantly decreased from 3.6 ± 0.8 at baseline to 0.3 ± 0.7 medications in group A (p = 0.000) and from 3.0 ± 1.0 to 0.3 ± 0.7 medications in group B (p = 0.000). Needling was required in 29% of eyes in group A and in 35% of group B within 12 months. No statistically significant differences were observed between eyes without and with prior glaucoma intervention. Conclusion The 1-year results of our retrospective analysis indicate that patients without and with previous glaucoma intervention can benefit from XEN45 gel stent implantation. Both groups achieved significant and similar reductions in IOP and hypotensive medication, with a slight trend towards greater reductions in eyes without prior glaucoma intervention. Further controlled prospective studies with longer follow-ups are required. Funding Editorial support and article processing charges were funded by Allergan.http://link.springer.com/article/10.1007/s40123-019-0193-7GlaucomaMinimally invasive glaucoma surgeryPrior glaucoma interventionXEN45 gel implant |
| spellingShingle | Fritz H. Hengerer Gerd Auffarth Ina Conrad-Hengerer Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies Ophthalmology and Therapy Glaucoma Minimally invasive glaucoma surgery Prior glaucoma intervention XEN45 gel implant |
| title | Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies |
| title_full | Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies |
| title_fullStr | Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies |
| title_full_unstemmed | Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies |
| title_short | Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies |
| title_sort | comparison of minimally invasive xen45 gel stent implantation in glaucoma patients without and with prior interventional therapies |
| topic | Glaucoma Minimally invasive glaucoma surgery Prior glaucoma intervention XEN45 gel implant |
| url | http://link.springer.com/article/10.1007/s40123-019-0193-7 |
| work_keys_str_mv | AT fritzhhengerer comparisonofminimallyinvasivexen45gelstentimplantationinglaucomapatientswithoutandwithpriorinterventionaltherapies AT gerdauffarth comparisonofminimallyinvasivexen45gelstentimplantationinglaucomapatientswithoutandwithpriorinterventionaltherapies AT inaconradhengerer comparisonofminimallyinvasivexen45gelstentimplantationinglaucomapatientswithoutandwithpriorinterventionaltherapies |